APPLICATION
ANDA076911
TYPE
ANDA
ORIGINAL APPROVAL
2004-09-29
LATEST ACTION
2010-11-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CLORAZEPATE DIPOTASSIUMDiscontinued
CLORAZEPATE DIPOTASSIUM 15MG · TABLET · ORAL
CLORAZEPATE DIPOTASSIUMDiscontinued
CLORAZEPATE DIPOTASSIUM 3.75MG · TABLET · ORAL
CLORAZEPATE DIPOTASSIUMDiscontinued
CLORAZEPATE DIPOTASSIUM 7.5MG · TABLET · ORAL
Approval history
2010-11-30Labeling · Supplement 5AP
2009-08-05Labeling · Supplement 4AP
2004-09-29OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.